Trade RARE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ultragenyx Pharmaceutical Inc. (RARE) is trading at US$15.30, up 3.03% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$2.55B. Over the past 52 weeks, RARE has traded between US$13.81 and US$39.89. On Syfe you can trade RARE with $0 commission and add it to your watchlist.
| Previous close | US$14.85 |
|---|---|
| Market cap | US$2.55B |
| 52-week range | US$13.81 – US$39.89 |
| Volume | 11.45M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.
Year: 2014
Ultragenyx Pharmaceutical Inc. (RARE) stock is trading at US$15.30, +3.03% from the previous close of US$14.85.
The market cap for Ultragenyx Pharmaceutical Inc. (RARE) stock is approximately US$2.55B.
The 52-week high for Ultragenyx Pharmaceutical Inc. (RARE) stock is US$39.89.
The 52-week low for Ultragenyx Pharmaceutical Inc. (RARE) stock is US$13.81.
Ultragenyx Pharmaceutical Inc. (RARE) does not currently pay a dividend.
Stay on top of RARE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
